{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:23:35Z","timestamp":1792214615729,"version":"4.4.0"},"reference-count":73,"publisher":"American Physiological Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Gastrointestinal and Liver Physiology"],"published-print":{"date-parts":[[2007,2]]},"abstract":"<jats:p>While CD8 subsets activate hepatic fibrosis, natural killer (NK) cells exhibit antifibrotic activity. Glatiramer acetate (GA) is an immune modulator for multiple sclerosis. We assessed the potential impact of GA on mouse hepatic fibrogenesis. Hepatic fibrosis was induced in C57BL\/6 mice by intraperitoneal administration of carbon tetrachloride (CCl<jats:sub>4<\/jats:sub>) for 6 wk. During the last 2 wk, animals were also treated with either GA (200 \u03bc\/day ip) or medium and compared with naive and fibrotic mice (8 animals\/group). GA markedly attenuated fibrosis without altering reactive oxygen species production. By morphometric measurement of Sirius red-stained tissue sections, the relative fibrosis area decreased from 5.28 \u00b1 0.32% (mean \u00b1 SE) in the untreated CCl<jats:sub>4<\/jats:sub>group to 2.01 \u00b1 0.28% in CCl<jats:sub>4<\/jats:sub>+GA-treated animals, compared with 0.38 \u00b1 0.07% in naive mice. \u03b1-Smooth muscle actin immunoblotting and mRNA expression revealed a similar pattern. Serum aminotransferase and Ishak-Knodell necroinflammatory score were markedly elevated, to the same extent, in both CCl<jats:sub>4<\/jats:sub>-treated groups. Fibrosis induction was associated with significant increase in CD8 subsets and decrease in CD4 T cells. After GA treatment, however, NK content, CD4<jats:sup>+<\/jats:sup>CD25<jats:sup>+<\/jats:sup>FoxP3<jats:sup>+<\/jats:sup>cells, hepatic expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), and apoptosis of hepatic stellate cells were all increased. Serum interleukin (IL)-10 levels markedly rose, whereas IL-4 fell. In vitro activation of human hepatic stellate cells cocultured with hepatitis C virus-derived peripheral blood lymphocytes decreased when lymphocytes were preincubated with GA before coculture. In an animal model of hepatic fibrosis, GA has an antifibrotic effect associated with decreased CD8 cells and reduced serum IL-4 levels and increased NK cells, CD4<jats:sup>+<\/jats:sup>CD25<jats:sup>+<\/jats:sup>FoxP3<jats:sup>+<\/jats:sup>cells, TRAIL, and elevated serum IL-10 levels.<\/jats:p>","DOI":"10.1152\/ajpgi.00137.2006","type":"journal-article","created":{"date-parts":[[2006,10,13]],"date-time":"2006-10-13T10:40:46Z","timestamp":1160736046000},"page":"G628-G638","source":"Crossref","is-referenced-by-count":28,"title":["Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosis"],"prefix":"10.1152","volume":"292","author":[{"given":"Amjad","family":"Horani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidal","family":"Muhanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orit","family":"Pappo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Melhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarit","family":"Doron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wehbi","family":"Wehbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karussis","family":"Dimitrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifaat","family":"Safadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"24","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200502000-00003"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2478(97)00032-1"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200108270-00007"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0404.2001.00125.x"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2005.03.018"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Allie R, Hu L, Mullen KM, Dhib-Jalbut S, Calabresi PA.Bystander modulation of chemokine receptor expression on peripheral blood T lymphocytes mediated by glatiramer therapy.Arch Neurol62: 889\u2013894, 2005.","DOI":"10.1001\/archneur.62.6.889"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1002\/jmr.628"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Belkaid Y, Rouse BT.Natural regulatory T cells in infectious disease.Nat Immun6: 353\u2013360, 2005.","DOI":"10.1038\/ni1181"},{"key":"R9","unstructured":"Boyum A.Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1g.Scand J Clin Lab Invest Suppl97: 77\u201389, 1968."},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7254.2006.00304.x"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1002\/ana.64"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.10.6435"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(03)00036-6"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.4.731"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.74.1.123"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Fridkis-Hareli M, Neveu JM, Robinson RA, Lane WS, Gauthier L, Wucherpfennig KW, Sela M, Strominger JL.Binding motifs of copolymer 1 to multiple sclerosis- and rheumatoid arthritis-associated HLA-DR molecules.J Immunol162: 4697\u20134704, 1999.","DOI":"10.4049\/jimmunol.162.8.4697"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00429-4"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.4.2247"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840150211"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.21045"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.2741\/A812"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5251.984"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.169.1.59"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2004.0957.x"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.301.3.1079"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2004.08.011"},{"key":"R27","unstructured":"Johnson KP, Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP, Myers LW, Panitch HS, Rose JW, Schiffer RB, Vollmer T, Weiner LP, Wolinsky JS.Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability.Neurology57: S46\u2013S53, 2001."},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1038\/86302"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200214380"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20032121"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2001.00189.x"},{"key":"R32","unstructured":"Khan OA, Tselis AC, Kamholz JA, Garbern JY, Lewis RA, Lisak RP.A prospective, open-label treatment trial to compare the effect of IFNbeta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis: results after 18 months of therapy.Mult Scler7: 349\u2013353, 2001."},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840010511"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1038\/nature03725"},{"key":"R35","doi-asserted-by":"crossref","unstructured":"Larmonier N, Marron M, Zeng Y, Cantrell J, Romanoski A, Sepassi M, Thompson S, Chen X, Andreansky S, Katsanis E.Tumor-derived CD4+CD25+regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10.Cancer Immunol Immunother2006.","DOI":"10.1007\/s00262-006-0160-8"},{"key":"R36","doi-asserted-by":"crossref","unstructured":"Longhi MS, Ma Y, Mitry RR, Bogdanos DP, Heneghan M, Cheeseman P, Mieli-Vergani G, Vergani D.Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis.J Autoimmun25: 63\u201371, 2005.","DOI":"10.1016\/j.jaut.2005.05.001"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.4.1127"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00293.2001"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.2.667"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.12.025"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70134-X"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(91)90198-O"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1131898100"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1023\/B:JOCI.0000019780.93817.82"},{"key":"R45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2003.08.001"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.10.055"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.07.041"},{"key":"R48","doi-asserted-by":"publisher","DOI":"10.2741\/A813"},{"key":"R49","unstructured":"Reinke LA, Moyer MJ.p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol.Drug Metab Dispos13: 548\u2013552, 1985."},{"key":"R50","doi-asserted-by":"publisher","DOI":"10.1159\/000073860"},{"key":"R51","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-005-0087-8"},{"key":"R52","unstructured":"Rockey DC, Boyles JK, Gabbiani G, Friedman SL.Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture.J Submicrosc Cytol Pathol24: 193\u2013203, 1992."},{"key":"R53","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000033800.93899.E1"},{"key":"R54","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.04.062"},{"key":"R55","doi-asserted-by":"crossref","unstructured":"Sakaguchi S.Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self.Nat Immun6: 345\u2013352, 2005.","DOI":"10.1038\/ni1178"},{"key":"R56","doi-asserted-by":"publisher","DOI":"10.1016\/S1521-6616(03)00020-2"},{"key":"R57","doi-asserted-by":"publisher","DOI":"10.1038\/nri821"},{"key":"R58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.20.10663"},{"key":"R59","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200216120-00004"},{"key":"R60","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.6.823"},{"key":"R61","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50002"},{"key":"R62","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280620"},{"key":"R63","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(92)90358-4"},{"key":"R64","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.12.7017"},{"key":"R65","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(95)00072-I"},{"key":"R66","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.9.4483"},{"key":"R67","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-003-0562-4"},{"key":"R68","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.1.302"},{"key":"R69","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.4.1367"},{"key":"R70","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.5.4.875"},{"key":"R71","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28423"},{"key":"R72","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v10.i17.2574"},{"key":"R73","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(99)00239-8"}],"container-title":["American Journal of Physiology-Gastrointestinal and Liver Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajpgi.00137.2006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T09:57:41Z","timestamp":1683626261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajpgi.00137.2006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["10.1152\/ajpgi.00137.2006"],"URL":"https:\/\/doi.org\/10.1152\/ajpgi.00137.2006","relation":{},"ISSN":["0193-1857","1522-1547"],"issn-type":[{"value":"0193-1857","type":"print"},{"value":"1522-1547","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}